Figure 1 summarizes three known mechanisms by which inhibition of CHEK2 in tumor cells promotes an immune response. Taken together, CHEK2 expression has the potential to predict resistance or non-response to immunotherapy. This evidence concerns the gene CHEK2 and neoplasm.